Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine
Clinical Psychopharmacology and Neuroscience
; : 181-183, 2017.
Article
de En
| WPRIM
| ID: wpr-203962
Bibliothèque responsable:
WPRO
ABSTRACT
Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Prolactine
/
Sérotonine
/
Norépinéphrine
/
Dépression
/
Trouble dépressif majeur
/
Chlorhydrate de venlafaxine
/
Galactorrhée
Limites du sujet:
Female
/
Humans
/
Pregnancy
langue:
En
Texte intégral:
Clinical Psychopharmacology and Neuroscience
Année:
2017
Type:
Article